These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33913225)

  • 1. Phosphor-signal transducers and activator of transcription 1 signaling in mucosal lichen planus developing from metastatic bladder cancer treated with pembrolizumab.
    Tamabuchi E; Fujimura T; Lyu C; Aiba S
    Dermatol Ther; 2021 Jul; 34(4):e14961. PubMed ID: 33913225
    [No Abstract]   [Full Text] [Related]  

  • 2. Lichen planus in a patient treated with pembrolizumab for metastatic malignant melanoma.
    Denny J; Chong H; Akhras V
    Clin Exp Dermatol; 2018 Apr; 43(3):354-356. PubMed ID: 29222829
    [No Abstract]   [Full Text] [Related]  

  • 3. Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic melanoma.
    Schmidgen MI; Butsch F; Schadmand-Fischer S; Steinbrink K; Grabbe S; Weidenthaler-Barth B; Loquai C
    J Dtsch Dermatol Ges; 2017 Jul; 15(7):742-745. PubMed ID: 28622432
    [No Abstract]   [Full Text] [Related]  

  • 4. Lichen planus pemphigoides with antibodies against the BP180 C-terminal domain induced by pembrolizumab in a melanoma patient.
    Yoshida S; Shiraishi K; Yatsuzuka K; Mori H; Koga H; Ishii N; Sayama K
    J Dermatol; 2021 Sep; 48(9):e449-e451. PubMed ID: 34089265
    [No Abstract]   [Full Text] [Related]  

  • 5. Pembrolizumab-induced pseudoepitheliomatous eruption consistent with hypertrophic lichen planus.
    Coscarart A; Martel J; Lee MP; Wang AR
    J Cutan Pathol; 2020 Mar; 47(3):275-279. PubMed ID: 31589773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic lichen planus-like eruption following pembrolizumab.
    Chapman S; Ashack K; Dapprich DC
    Cutis; 2021 Jan; 107(1):E10-E11. PubMed ID: 33651868
    [No Abstract]   [Full Text] [Related]  

  • 7. Case of lichen planus pemphigoides after pembrolizumab therapy for advanced urothelial carcinoma.
    Okada H; Kamiya K; Murata S; Sugihara T; Sato A; Maekawa T; Komine M; Ohtsuki M
    J Dermatol; 2020 Sep; 47(9):e321-e322. PubMed ID: 32515025
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe progressive scarring pembrolizumab-induced lichen planopilaris in a patient with metastatic melanoma.
    Uthayakumar AK; Rudd E; Noy M; Weir J; Larkin J; Fearfield L
    Australas J Dermatol; 2021 Aug; 62(3):403-406. PubMed ID: 34216144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive lichen planopilaris as exclusive lichenoid reaction secondary to pembrolizumab in a patient with metastatic melanoma.
    Garcia-Melendo C; Morales-Munera CE; Dalmau J; Cubiró X; López-Sánchez C; Mozos A; Yélamos O
    Dermatol Ther; 2022 May; 35(5):e15388. PubMed ID: 35174945
    [No Abstract]   [Full Text] [Related]  

  • 10. Unilateral Blaschkoid-linear verrucous lichen planus under immunotherapy with pembrolizumab.
    Gambichler T; Kautz O; Schacht R; Boms S
    J Eur Acad Dermatol Venereol; 2023 May; 37(5):e624-e625. PubMed ID: 36394377
    [No Abstract]   [Full Text] [Related]  

  • 11. Avelumab-induced lichen planopilaris, a novel association.
    Dominguez-Santas M; Fernandez-Nieto D; Diaz-Guimaraens B; Suarez-Valle A; Jimenez-Cauhe J; Saceda-Corralo D
    Int J Dermatol; 2021 Oct; 60(10):e414-e416. PubMed ID: 33826153
    [No Abstract]   [Full Text] [Related]  

  • 12. Atezolizumab-induced lichen planus pemphigoides in a patient with metastatic non-small-cell lung cancer.
    Senoo H; Kawakami Y; Yokoyama E; Yamasaki O; Morizane S
    J Dermatol; 2020 Apr; 47(4):e121-e122. PubMed ID: 31984550
    [No Abstract]   [Full Text] [Related]  

  • 13. Lichen planus pemphigoides during therapy with tislelizumab and sitravatinib in a patient with metastatic lung cancer.
    Kerkemeyer KLS; Lai FYX; Mar A
    Australas J Dermatol; 2020 May; 61(2):180-182. PubMed ID: 31808542
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lichen planus and lichen planus pigmentosus following gold therapy--case reports and review of the literature].
    Ingber A; Weissmann-Katzenelson V; David M; Bialowons M; Feuerman EJ
    Z Hautkr; 1986 Mar; 61(5):315-9. PubMed ID: 3083615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Yellow Plaques in a Patient Taking Pembrolizumab.
    Massey PR; Jones KM; Fox MC
    JAMA Oncol; 2017 Jan; 3(1):119-120. PubMed ID: 27892986
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of lichen planus following benralizumab treatment.
    Morimoto H; Fukuchi K; Ogura Y; Ohtsuka M; Tokura Y
    Eur J Dermatol; 2021 Apr; 31(2):261-262. PubMed ID: 33814362
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of recalcitrant lichen planus pemphigoides with tildrakizumab.
    Kerkemeyer KL; Pinczewski J; Sinclair R
    Australas J Dermatol; 2020 Aug; 61(3):e366-e368. PubMed ID: 32141608
    [No Abstract]   [Full Text] [Related]  

  • 18. Dupilumab for the Treatment of Lichen Planus.
    Pousti BT; Jin A; Sklovar L; Savage KT; Zhai LL; Mollanazar NK; Heath CR
    Cutis; 2021 Apr; 107(4):E8-E10. PubMed ID: 34096853
    [No Abstract]   [Full Text] [Related]  

  • 19. Lichen planus under anti TNF therapy for ankylosing spondylitis.
    Wendling D; Biver-Dalle C; Vidon C; Prati C; Aubin F
    Joint Bone Spine; 2013 Mar; 80(2):227-8. PubMed ID: 23453473
    [No Abstract]   [Full Text] [Related]  

  • 20. Ulcerated Lichen Planus after Adjuvant Use of Programmed Cell Death-1-Inhibitor: A Case Report and Systematic Review of the Literature.
    Niesert AC; Guertler A; Schutti O; Engels L; Flaig M; French LE; Schlaak M; Reinholz M
    Acta Derm Venereol; 2021 Jun; 101(6):adv00472. PubMed ID: 34043014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.